What SEROQUEL Does
-
SEROQUEL has been proven effective in treating both depressive episodes and acute
manic episodes in bipolar disorder in adults
-
SEROQUEL has been proven effective in long-term maintenance treatment of bipolar
disorder in combination with lithium or divalproex in adults
-
SEROQUEL has also been proven effective in treating schizophrenia in adults
-
SEROQUEL has been proven effective in treating manic episodes in bipolar disorder in children and adolescents ages 10 to 17 years, and in treating schizophrenia in adolescents ages 13-17 years
-
Millions of people have been treated with SEROQUEL in the US
SEROQUEL has been on the market for over 10 years and has been prescribed to millions
of patients in the US. SEROQUEL is approved for the treatment of bipolar
disorder and schizophrenia. SEROQUEL has been evaluated in clinical trials with
thousands of patients. As with all medications, SEROQUEL continues to be regulated
and reviewed by the FDA today.
Bipolar Disorder
In clinical studies, adults treated for the highs of bipolar mania showed these types of improvements in symptoms of bipolar mania:
-
Fewer racing thoughts
-
More normal sleep
-
Improved insight
-
Less irritability
In clinical studies, adults treated for the lows of bipolar depression showed these types of improvements in symptoms of bipolar depression:
-
Less sadness
-
More normal sleep
-
Less pessimism
-
Less edgy and tense
Schizophrenia
The efficacy of SEROQUEL in the treatment of schizophrenia in adults was established in 3
short-term (6-week) clinical trials in patients with schizophrenia. In clinical studies,
people treated for schizophrenia showed improvement in symptoms of schizophrenia such as:
-
Unusual thoughts
-
Suspiciousness
-
Hallucinations
The efficacy of SEROQUEL in the treatment of schizophrenia in adolescents was established in one short-term (6-week) clinical trial in patients with schizophrenia.
Learn about the side effects associated with SEROQUEL
>>